Skip to content

Female Breast Upper Inner Quadrant Cancer C0153550

Published: July 22, 2026Updated: August 20, 2026

A malignant tumor occurring in the upper inner portion of the female breast. Primarily affects females and is evaluated based on specific tumor features. Treatment options depend on cancer characteristics and spread.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Palpable mass in upper inner quadrant

!

Skin changes overlying mass

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Nipple inversion

(oncologic)

Medial arm swelling

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Partial Mastectomy with Oncoplastic Technique

Combined tumor removal with plastic surgery reconstruction to maintain breast shape and symmetry, particularly relevant for upper inner quadrant where cosmetic outcomes are more visible.

surgical
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Image-Guided Wire Localization

Precise pre-surgical localization of the tumor using imaging guidance to ensure adequate margins in the upper inner quadrant.

procedure

Additional treatment options

Neoadjuvant Chemotherapy

Chemotherapy administered before surgery to shrink tumors, potentially enabling breast conservation in larger tumors.

medication

Accelerated Partial Breast Irradiation

Shortened course of focused radiation targeting only the tumor cavity area, suitable for selected low-risk patients.

procedure

Integrative Oncology Support

Evidence-based complementary therapies including acupuncture for treatment-related symptoms, yoga for quality of life, and nutritional counseling.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Female Breast Upper Inner Quadrant Cancer C0153550?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Female Breast Upper Inner Quadrant Cancer C0153550. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy